Google Ventures-incubated biotech raises $77M for drugs targeting ‘repeatome’

Armed with $77 million in new funding, Rome Therapeutics — the second-ever biotech company to be incubated by Google’s venture arm — is looking to double or even triple in the next two years as it develops a new pipeline of drugs.